Dentsply Sirona's Simon Campion Steps Down, Daniel Scavilla Assumes CEO Role

Dentsply Sirona Inc. (XRAY) has officially announced a major leadership transition, with Simon Campion stepping down from his position as President and Chief Executive Officer. The departure will become effective on July 31, 2025, marking the end of Campion’s tenure at the global dental equipment manufacturer. Taking the helm on August 1, 2025, is Daniel Scavilla, who brings extensive healthcare leadership experience from his prior role as President and CEO of Globus Medical, Inc. (GMED).

Leadership Change Reflects Strategic Evolution

The transition represents a significant moment for the Connecticut-based company as it navigates evolving market demands in the dental and medical device sectors. Simon Campion’s exit follows the company’s broader strategic positioning, while Scavilla’s appointment signals a new leadership direction. The 2025 leadership change underscores the board’s confidence in bringing fresh perspective to guide the company through its next growth phase.

Q2 Financial Results Paint Cautious Picture

Alongside the executive transition announcement, Dentsply Sirona released preliminary second-quarter results for the period ending June 30, 2025. The company reported expected net sales of approximately $935 million, with adjusted earnings projected between $0.50 and $0.52 per share. These financial metrics reflect the company’s operational performance amid a competitive market landscape. In pre-market trading on the Nasdaq, XRAY shares moved to $16, representing a 2.04 percent gain as investors processed the leadership news and quarterly performance data.

The simultaneous announcement of both leadership transition and financial results suggests the company is positioning itself for renewal under new executive guidance while maintaining operational stability during the transition period.